Table 1 Demographic and clinical data of patients
From: Myofascial trigger points in cluster headache patients: a case series
Patient | Sex | Age | Diagnosis (location) | Illness duration (years) | Attacks' frequency (daily) | Current prophylactic drugs |
|---|---|---|---|---|---|---|
1 | M | 45 | episodic (R) | 20 | 1–2 | ------ |
2 | M | 39 | episodic (L) | 21 | 1 | ------ |
3 | M | 40 | episodic (A) | 12 | 3–4 | ------ |
4 | M | 51 | episodic (R) | 12 | 2 | ------ |
5 | M | 43 | chronic (A) | 13 | 1–2 | verapamil |
6 | M | 48 | chronic (A) | 21 | 3–4 | valproate |
7 | M | 47 | chronic (L) | 10 | 1–4 | verapamil + lithium |
8 | M | 36 | chronic (A) | 16 | 5–6 | verapamil+gabapentin+baclofen |
9 | M | 33 | chronic (R) | 25 | 3–4 | daily zolmitriptan |
10 | M | 31 | chronic (R) | 4 | 4 | verapamil+lithium+valproate |
11 | M | 46 | chronic (L) | 2 | 2 | verapamil |
12 | M | 38 | chronic (L) | 6 | 1–2 | prednisone |